SELLAS Life Sciences Group, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications. The company's lead product candidate is galinpepimut-S (GPS), a wilms tumor 1 targeting peptide-based cancer immunotherapeutic agent, which has entered in Phase III clinical trials for the treatment of acute myeloid leukemia; and is in various development phases as a potential treatment for ovarian cancer. It also develops nelipepimut-S (NPS) that is in Phase 2b clinical trials for the treatment of breast cancer; GALE-301 and GALE-302, which is in Phase 1/2a trials in ovarian and endometrial cancers. The company has strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and Advaxis, Inc. on a research program to evaluate, through a proof of principle trial, a clinical candidate, which comprises the combination of proprietary Lm-based antigen delivery technology and GPS. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/26/2020 07:46 PDT] SLS Expected to Trade Up After Bullish Patterns Develop
• [05/11/2020 13:20 PDT] SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), Up By 100.00% ($2.61) From $2.610 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/08/2020 07:31 PDT] SLS Expected to Trade Up Short Term
• [05/06/2020 10:10 PDT] SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), Up By 100.00% ($2.55) From $2.550 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/01/2020 07:33 PDT] SLS Expected to Trade Up Short Term
• [04/16/2020 08:13 PDT] SLS Expected to Trade Down After Bearish Patterns Develop
• [04/15/2020 08:12 PDT] SLS Expected to Trade Down After Bearish Patterns Develop